| scholarly article | Q13442814 |
| P50 | author | Aditya Ambade | Q39682997 |
| Pranoti S. Mandrekar | Q68342340 | ||
| P2093 | author name string | Donna Catalano | |
| Gyongyi Szabo | |||
| Arlene Lim | |||
| P2860 | cites work | Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors | Q28326688 |
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 | ||
| C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis | Q33750735 | ||
| Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury | Q33888042 | ||
| Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease | Q33926138 | ||
| Molecular regulation of adipogenesis | Q34059685 | ||
| Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines | Q34662656 | ||
| CC chemokine receptor-coupled signalling pathways. | Q35213130 | ||
| Recent insights into the role of the innate immune system in the development of alcoholic liver disease. | Q35216526 | ||
| Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity | Q35537187 | ||
| Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production | Q35962815 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury | Q36645721 | ||
| Signaling mechanisms in alcoholic liver injury: role of transcription factors, kinases and heat shock proteins | Q36939995 | ||
| Integration of metabolism and inflammation by lipid-activated nuclear receptors | Q37225357 | ||
| CCR2 promotes hepatic fibrosis in mice | Q37249670 | ||
| The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes | Q37354457 | ||
| MCP-1 protects mice in lethal endotoxemia | Q37368530 | ||
| Signalling pathways in alcohol-induced liver inflammation. | Q37461766 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia | Q39471490 | ||
| Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes | Q39969772 | ||
| Chemokines, inflammation and the immune system | Q40429479 | ||
| Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition | Q40882321 | ||
| Alcohol and lipid metabolism | Q41328834 | ||
| Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. | Q41892979 | ||
| Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. | Q42136491 | ||
| Chronic alcohol intoxication primes Kupffer cells and endothelial cells for enhanced CC-chemokine production and concomitantly suppresses phagocytosis and chemotaxis | Q42521995 | ||
| Chemokines: leucocyte recruitment and activation cytokines. | Q44208652 | ||
| Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation. | Q46891936 | ||
| C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. | Q53767913 | ||
| Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice | Q60321190 | ||
| Effect of chronic alcohol consumption on total plasma homocysteine level in rats | Q73702269 | ||
| Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis | Q77753237 | ||
| Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? | Q78580447 | ||
| Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver | Q83182716 | ||
| Oxidative stress and alcoholic liver disease | Q83707371 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | 2185-2197 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice | |
| P478 | volume | 54 |
| Q41564669 | 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα. |
| Q28240106 | Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice |
| Q36774034 | Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury |
| Q40071068 | Activation of autophagy attenuates EtOH-LPS-induced hepatic steatosis and injury through MD2 associated TLR4 signaling |
| Q36578908 | Adipose tissue-liver axis in alcoholic liver disease |
| Q47139935 | Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription. |
| Q37465289 | Air pollution-mediated susceptibility to inflammation and insulin resistance: influence of CCR2 pathways in mice |
| Q49994994 | Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. |
| Q37423026 | Alcohol-induced liver injury is modulated by Nlrp3 and Nlrc4 inflammasomes in mice |
| Q38759707 | Alcoholic hepatitis: Translational approaches to develop targeted therapies |
| Q60046008 | Alcoholic liver disease: Utility of animal models |
| Q38381594 | Alcoholic liver disease: mechanisms of injury and targeted treatment |
| Q54217913 | Alleviation of high-fat diet-induced atherosclerosis and glucose intolerance by a novel GLP-1 fusion protein in ApoE(-/-) mice. |
| Q91213178 | Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis |
| Q34777499 | Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis |
| Q39177349 | C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation |
| Q49187592 | CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway. |
| Q33882408 | CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis |
| Q34625795 | CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance |
| Q41900013 | CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models |
| Q34586647 | Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis |
| Q35060993 | Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies |
| Q35691489 | Changes in LDL Oxidative Status and Oxidative and Inflammatory Gene Expression after Red Wine Intake in Healthy People: A Randomized Trial |
| Q42688383 | Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice |
| Q28082228 | Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction |
| Q34178620 | Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice |
| Q37707790 | Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver. |
| Q44297085 | Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma |
| Q64076774 | Comparative Transcriptome Analyses Provide Potential Insights into the Molecular Mechanisms of Astaxanthin in the Protection against Alcoholic Liver Disease in Mice |
| Q59789588 | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD |
| Q37040722 | Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis |
| Q35375422 | Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury |
| Q89993262 | Effect of Tff3 Deficiency and ER Stress in the Liver |
| Q57729861 | Effect of adipose tissue-derived mesenchymal stem cell treatment on oxidative stress and inflammatory response following Escherichia coli lipopolysaccharide |
| Q30234425 | Emerging concepts in alcoholic hepatitis |
| Q28547669 | Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases |
| Q51641836 | Exploring an animal model of amodiaquine-induced liver injury in rats and mice. |
| Q51664532 | Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. |
| Q54117341 | Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease. |
| Q38275213 | Gut-liver axis in alcoholic liver disease |
| Q47143305 | Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice |
| Q84723541 | Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates |
| Q38814432 | Hepatic hazard assessment of silver nanoparticle exposure in healthy and chronically alcohol fed mice |
| Q36870030 | Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies |
| Q47114035 | Hepatic toxicity assessment of cationic liposome exposure in healthy and chronic alcohol fed mice. |
| Q51221988 | Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. |
| Q36309557 | Hepatocyte-specific ablation of spermine/spermidine-N1-acetyltransferase gene reduces the severity of CCl4-induced acute liver injury |
| Q26774699 | Hepatocytes: a key cell type for innate immunity |
| Q27027380 | Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease |
| Q55304054 | Hepatoprotective effects of Auricularia cornea var. Li. polysaccharides against the alcoholic liver diseases through different metabolic pathways. |
| Q55039176 | Humanized mice reveal an essential role for human hepatocytes in the development of the liver immune system. |
| Q27008536 | IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice |
| Q38161295 | Immune cells and metabolic dysfunction |
| Q36104223 | Immunity and inflammatory signaling in alcoholic liver disease |
| Q91816495 | In Vivo Hepatoprotective Effects of a Peptide Fraction from Krill Protein Hydrolysates against Alcohol-Induced Oxidative Damage |
| Q35814440 | Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats |
| Q38521274 | Inflammasome activation and function in liver disease |
| Q36895048 | Inflammation in alcoholic liver disease |
| Q36355631 | Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease |
| Q42182595 | Inhibitory Effect of 3-(4-Hydroxyphenyl)-1-(thiophen-2-yl) prop-2-en-1-one, a Chalcone Derivative on MCP-1 Expression in Macrophages via Inhibition of ROS and Akt Signaling |
| Q38245446 | Innate immunity and cell death in alcoholic liver disease: role of cytochrome P4502E1. |
| Q33792887 | Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System |
| Q36674421 | Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration |
| Q36952084 | Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes |
| Q35930758 | Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells |
| Q51741688 | Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80+Clec4f+Vsig4+Ly6C- Kupffer Cell Subsets. |
| Q64946007 | Liver Macrophages: Old Dogmas and New Insights. |
| Q55401276 | Liver X receptors regulate hepatic F4/80 + CD11b+ Kupffer cells/macrophages and innate immune responses in mice. |
| Q39187324 | Liver macrophages in tissue homeostasis and disease |
| Q36980410 | Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury |
| Q89666166 | Macrophage Phenotype and Function in Liver Disorder |
| Q36684985 | Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis |
| Q26771553 | Macrophages and Alcohol-Related Liver Inflammation |
| Q35861037 | MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells |
| Q101133373 | Molecular and cellular mechanisms of liver fibrosis and its regression |
| Q54483243 | Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice. |
| Q37210744 | Mouse model of chronic and binge ethanol feeding (the NIAAA model) |
| Q89108940 | Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q37739608 | NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease. |
| Q33746508 | New drug targets for alcoholic liver disease |
| Q33757267 | New therapeutic targets in alcoholic hepatitis |
| Q99712219 | Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities |
| Q33761629 | Novel Akt activator SC-79 is a potential treatment for alcohol-induced osteonecrosis of the femoral head |
| Q90143394 | Novel Role of Macrophage Migration Inhibitory Factor in Upstream Control of the Unfolded Protein Response After Ethanol Feeding in Mice |
| Q52718576 | Opposing actions of developmental trichloroethylene and high-fat-diet co-exposure on markers of lipogenesis and inflammation in autoimmune-prone mice. |
| Q64926676 | Optimal ratio of 18α- and 18β-glycyrrhizic acid for preventing alcoholic hepatitis in rats. |
| Q47138145 | Oxidative products from alcohol metabolism differentially modulate pro-inflammatory cytokine expression in Kupffer cells and hepatocytes. |
| Q35816465 | Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence |
| Q91281532 | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice |
| Q93155221 | Phenotypical and Functional Polymorphism of Liver Resident Macrophages |
| Q30375693 | Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. |
| Q57821804 | Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-B Signaling Pathways in Mice |
| Q36588873 | RORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure |
| Q91813163 | Regulatory T cells suppress excessive lipid accumulation in alcoholic liver disease |
| Q55516318 | Role of Hepatic Deposited Immunoglobulin G in the Pathogenesis of Liver Damage in Systemic Lupus Erythematosus. |
| Q93357404 | Roles of the inflammasome in the gut‑liver axis (Review) |
| Q55025882 | Silymarin Prevents Restraint Stress-Induced Acute Liver Injury by Ameliorating Oxidative Stress and Reducing Inflammatory Response. |
| Q97542802 | Sphingosine 1-phosphate/microRNA-1249-5p/MCP-1 axis is involved in macrophage-associated inflammation in fatty liver injury in mice |
| Q52574737 | Synergistic effect of interleukin-17 and tumor necrosis factor-α on inflammatory response in hepatocytes through interleukin-6 dependent and independent pathways. |
| Q91632128 | Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice |
| Q39392481 | Targeting inflammation for the treatment of alcoholic liver disease |
| Q38829170 | Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma |
| Q26773226 | The Role of Innate Immunity in Alcoholic Liver Disease |
| Q64093135 | The Role of Myeloid-Derived Cells in the Progression of Liver Disease |
| Q38175384 | The effect of inflammatory cytokines in alcoholic liver disease. |
| Q52327759 | The innate immune response to ischemic injury: a multiscale modeling perspective. |
| Q36922236 | The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis |
| Q54224246 | The role of IL-22 in the resolution of sterile and nonsterile inflammation. |
| Q90024070 | The role of sphingosine kinase 2 in alcoholic liver disease |
| Q42367659 | Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis |
| Q57281933 | Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice |
| Q37686240 | Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models. |
| Q39266499 | Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation. |
| Q38686560 | Young adult binge drinkers have immunophenotypic changes in peripheral polymorphonuclear cells and monocytes |
Search more.